1-Hydroxyoxaunomycin

Drug Profile

1-Hydroxyoxaunomycin

Alternative Names: 1-Hydroxy-D788-7

Latest Information Update: 20 Oct 1995

Price : $50

At a glance

  • Originator Mercian
  • Class Cytostatic antibiotics
  • Mechanism of Action DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 20 Oct 1995 Discontinued-Preclinical for Cancer in Japan (Unknown route)
  • 30 Jun 1995 A preclinical study has been added to the Cancer pharmacodynamics section .
  • 22 Jun 1995 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top